Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2. 1992

T N Turner, and C L Smith, and G A Bohach
Department of Bacteriology and Biochemistry, University of Idaho, Moscow 83843.

Nonconserved residues of staphylococcal enterotoxin C1 (SEC1) were converted to their counterparts in SEC2. The mutants that resulted were examined for reactivity with monoclonal antibodies (MAbs). Substitution at position 20, 22, or 26 interfered with binding of an SEC1-specific MAb. SEC1 mutants with substitutions at all three positions reacted only with an SEC2-specific MAb. Antibody-binding patterns were not associated with isoelectric point differences. All mutants retained biological activity.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

T N Turner, and C L Smith, and G A Bohach
July 1989, Infection and immunity,
T N Turner, and C L Smith, and G A Bohach
February 1990, Applied and environmental microbiology,
T N Turner, and C L Smith, and G A Bohach
February 1980, Infection and immunity,
T N Turner, and C L Smith, and G A Bohach
January 1993, The Journal of experimental medicine,
T N Turner, and C L Smith, and G A Bohach
August 1995, Nature structural biology,
T N Turner, and C L Smith, and G A Bohach
December 1983, Applied and environmental microbiology,
T N Turner, and C L Smith, and G A Bohach
December 1967, Japanese journal of microbiology,
T N Turner, and C L Smith, and G A Bohach
May 1991, FEMS microbiology letters,
T N Turner, and C L Smith, and G A Bohach
January 1984, Veterinarno-meditsinski nauki,
Copied contents to your clipboard!